Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.20.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock
Common Stock
Additional Paid-in- Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Effect of new accounting adoption           $ 1,623 $ 1,623
Balance as currently reported at, December 29, 2018 (in shares) 2,771 34,992          
Balance as currently reported at, December 29, 2018 $ 3 $ 38 $ 183,139 $ (7,146) $ 579 (136,168) 40,445
Beginning balance (in shares) at Dec. 29, 2018 2,771 34,992          
Beginning balance at Dec. 29, 2018 $ 3 $ 38 183,139 (7,146) 579 (137,791) 38,822
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss           (3,581) (3,581)
Issuance of shares in connection with restricted stock units vesting (in shares)   437          
Issuance of shares in connection with restricted stock units vesting     (288)       (288)
Issuance of shares in connection with BOD Fees (in shares)   4          
Issuance of shares in connection with BOD Fees     4       4
Share-based compensation     554       554
Common stock dividend on preferred stock           39 39
Effect of changes in foreign currencies         (5)   (5)
Ending balance (in shares) at Mar. 30, 2019 2,771 35,433          
Ending balance at Mar. 30, 2019 $ 3 $ 38 183,409 (7,146) 574 (139,788) 37,090
Beginning balance (in shares) at Dec. 28, 2019 2,771 36,167          
Beginning balance at Dec. 28, 2019 $ 3 $ 38 187,147 (7,146) 214 (167,876) 12,380
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss           (978) $ (978)
Issuance of shares in connection with stock option exercises (in shares)   523         523
Issuance of shares in connection with stock option exercise   $ 1 1,119       $ 1,120
Issuance of shares in connection with restricted stock units vesting (in shares)   1,809          
Issuance of shares in connection with restricted stock units vesting   $ 2 (86)       (84)
Issuance of shares in connection with BOD Fees (in shares)   3          
Issuance of shares in connection with BOD Fees     6       6
Share-based compensation     2,819       2,819
Conversion of preferred stock (in shares) (150) 150          
Unrealized loss on deferred compensation trust assets         (95)   (95)
Common stock dividend on preferred stock     (38)     39 1
Common stock dividend on preferred stock (in shares)   20          
Effect of changes in foreign currencies         (6)   (6)
Ending balance (in shares) at Mar. 28, 2020 2,621 38,672          
Ending balance at Mar. 28, 2020 $ 3 $ 41 $ 191,043 $ (7,146) $ 113 $ (168,893) $ 15,161